X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.ema.europa.eu/en/documents/overview/aqumeldi-epar-medicine-overview_en.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-13-2022-1657691440.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213714
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214467
https://psnc.org.uk/our-news/medicine-supply-notification-enalapril-20mg-tablets-various-suppliers/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212894
https://www.biospace.com/article/newly-branded-azurity-wins-fda-approval-for-liquid-form-of-amlodipine/
https://www.ema.europa.eu/documents/psusa/enalapril-list-nationally-authorised-medicinal-products-psusa/00001211/201803_en.pdf
https://www.pharmacompass.com/pdf/news/epaned-enalapril-maleate-oral-solution-silvergate-pharms-v-bionpharma-1546969377.pdf
https://www.prnewswire.com/news-releases/new-novartis-study-supports-entresto-as-foundational-hfref-therapy-and-in-hospital-initiation-in-appropriate-stabilized-heart-failure-patients-300748028.html
https://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/UCM293268.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-epaned-208686-enalapril-maleate-oral-solution-1541063117.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-1-2018-1533104328.pdf
https://www.pharmacompass.com/pdf/news/Enforcement-Report-Week-of-July-18-2018-1531894333.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-22-2017-1511333424.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-1-2017-1509512060.pdf
http://www.fiercepharma.com/corporate/after-a-slow-start-novartis-gains-market-traction-heart-drug-entresto
https://www.pharmacompass.com/pdf/news/silvergate-pharms-generic-epaned-approved-in-us-1474551907.pdf
http://www.financialexpress.com/article/fe-columnist/editorial-making-pharma-sick/234326/
http://www.pharma-excipients.ch/2016/03/21/influence-of-different-types-of-commercially-availablemicrocrystalline-cellulose-on-degradation-of-perindopril-erbumine-and-enalapril-maleate-in-binary-mixtures/
http://www.pharma-excipients.ch/2016/02/07/buccal-transmucosal-delivery-system-of-enalapril-for-improved-cardiac-drug-delivery-preparation-and-characterization/
http://www.prnewswire.com/news-releases/epaned-enalapril-maleate-oral-solution-1-mgml-the-first-and-only-fda-approved-enalapril-oral-solution-for-the-treatment-of-pediatric-hypertension-in-patients-older-than-1-month-is-now-available-300388989.html
http://www.reuters.com/article/2015/11/13/us-health-access-heart-drugs-idUSKCN0T22ED20151113
http://www.prnewswire.com/news-releases/novartis-heart-failure-medicine-entresto-substantially-cuts-30-day-hospital-readmissions-new-post-hoc-analysis-shows-300176067.html
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/anvisa+suspende+medicamento+que+era+comercializado+com+registro+cancelado
http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/2015/lote+do+medicamento+renopril+esta+suspenso+pela+anvisa
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30
Market Place
Share 
